CDSCO Panel tells Intas on antipsychotic Drug Endoxifen
New Delhi: Noting that the study drug Endoxifen is already approved in India since 10-12-2019 for proposed indication, the Subject Expert Committtee (SEC) functional under the Central Drug Standard Control…